Tenderwize
Wróć do wyszukiwania

Safinamid_TK, HEK, hkk

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2027 · 247 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-06 - Safinamid

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

30 / 100

Czynniki ryzyka

No guaranteed volume or minimum purchase; the actual revenue depends on the number of prescriptions and competition.

Submission deadlines for timely pharmacy software inclusion are strict (3rd of previous month). Late submissions may de...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount agreements for Safinamid pharmaceutical products under §130a Abs. 8 SGB V.
  • Contract covers all exchangeable finished medicinal products of the contractor.
Pokaż pełne podsumowanie

Open-house discount agreement procedure for pharmaceutical product Safinamid, conducted by Techniker Krankenkasse (TK) on behalf of HEK and hkk. The goal is to conclude non-exclusive rebate contracts with all eligible pharmaceutical entrepreneurs. Contract duration max 12 months from 01.05.2026 to 30.04.2027. Participation possible at any time during the contract period. No individual negotiations; uniform conditions.

Ryzyka

No guaranteed volume or minimum purchase; the actual revenue depends on the number of prescriptions and competition.

Submission deadlines for timely pharmacy software inclusion are strict (3rd of previous month). Late submissions may de...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur within the meaning of §4 Abs. 18 AMG for the offered medicinal products.
  • Company seat must be in Germany, another EU member state, or EEA state (§9 Abs.2 AMG).
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs for the offered products.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Safinamid_TK, HEK, hkk

Discount agreement for Safinamid active ingredient. Scope covers all exchangeable finished medicinal products of the contractor as per framework agreement. Participation of HEK and/or hkk depends on lot designation.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Apr 2026 - Apr 2027

Kategoria

Pharmaceutical products

Termin

Deadline Apr 29, 2027

Szczegóły zamówienia

Data publikacji
26 Mar 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
214489-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3